1. Home
  2. DNLI vs CUBI Comparison

DNLI vs CUBI Comparison

Compare DNLI & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • CUBI
  • Stock Information
  • Founded
  • DNLI 2013
  • CUBI 1994
  • Country
  • DNLI United States
  • CUBI United States
  • Employees
  • DNLI N/A
  • CUBI N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • CUBI Major Banks
  • Sector
  • DNLI Health Care
  • CUBI Finance
  • Exchange
  • DNLI Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • DNLI 2.5B
  • CUBI 2.3B
  • IPO Year
  • DNLI 2017
  • CUBI 2012
  • Fundamental
  • Price
  • DNLI $19.09
  • CUBI $70.00
  • Analyst Decision
  • DNLI Strong Buy
  • CUBI Strong Buy
  • Analyst Count
  • DNLI 13
  • CUBI 6
  • Target Price
  • DNLI $32.64
  • CUBI $83.17
  • AVG Volume (30 Days)
  • DNLI 1.4M
  • CUBI 252.7K
  • Earning Date
  • DNLI 11-06-2025
  • CUBI 10-23-2025
  • Dividend Yield
  • DNLI N/A
  • CUBI N/A
  • EPS Growth
  • DNLI N/A
  • CUBI N/A
  • EPS
  • DNLI N/A
  • CUBI 4.96
  • Revenue
  • DNLI N/A
  • CUBI $651,983,000.00
  • Revenue This Year
  • DNLI N/A
  • CUBI $17.16
  • Revenue Next Year
  • DNLI $94,232.03
  • CUBI $13.27
  • P/E Ratio
  • DNLI N/A
  • CUBI $14.13
  • Revenue Growth
  • DNLI N/A
  • CUBI N/A
  • 52 Week Low
  • DNLI $10.57
  • CUBI $40.75
  • 52 Week High
  • DNLI $26.18
  • CUBI $72.51
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 69.43
  • CUBI 60.82
  • Support Level
  • DNLI $16.85
  • CUBI $63.44
  • Resistance Level
  • DNLI $18.21
  • CUBI $67.22
  • Average True Range (ATR)
  • DNLI 1.17
  • CUBI 2.30
  • MACD
  • DNLI 0.23
  • CUBI 0.15
  • Stochastic Oscillator
  • DNLI 90.65
  • CUBI 90.57

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: